Serial Number | 90379452 |
Word Mark | THANOCRINE |
Filing Date | Monday, December 14, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, January 30, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 2, 2021 |
Goods and Services | Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation |
Goods and Services | Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, February 21, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 15, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SONATA THERAPEUTICS, INC. |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 03 - Corporation |
Address | CAMBRIDGE, MA 02142 |
Party Name | Inzen Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02142 |
Party Name | Inzen Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02142 |
Event Date | Event Description |
Monday, January 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, January 30, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, January 4, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Friday, June 24, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, June 22, 2022 | SOU EXTENSION 1 GRANTED |
Wednesday, June 22, 2022 | SOU EXTENSION 1 FILED |
Wednesday, June 22, 2022 | TEAS EXTENSION RECEIVED |
Tuesday, December 28, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, November 2, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 2, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, October 13, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 28, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, September 15, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, September 14, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, September 14, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 23, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, March 23, 2021 | NON-FINAL ACTION E-MAILED |
Tuesday, March 23, 2021 | NON-FINAL ACTION WRITTEN |
Monday, March 22, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, March 22, 2021 | NON-FINAL ACTION E-MAILED |
Monday, March 22, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, March 17, 2021 | ASSIGNED TO EXAMINER |
Sunday, February 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |